Appearing for Dr. Reddy’s, Senior Advocates Abhishek Manu Singhvi and Mukul Rohatgi submitted that Dr. Reddy’s had obtained a licence to manufacture the drug in December 2024 and had begun manufacturing the drug in April 2025.
However, they clarified…
